8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General693 citations

Effects of Pulsed Electromagnetic Field Therapy at Different Frequencies on Bone Mass and Microarchitecture in Osteoporotic Mice

Bioeffects Seen

Wang L, Li Y, Xie S, Huang J, Song K, He C · 2021

Share:

The study evaluated PEMF therapy as a potential non-pharmacological intervention for osteoporosis by testing frequency-dependent effects on bone health outcomes in mice.

Plain English Summary

Summary written for general audiences

This 2021 study investigated how pulsed electromagnetic field (PEMF) therapy at varying frequencies affects bone mass and microarchitecture in an osteoporotic mouse model. The research examined whether different PEMF frequencies could modify bone density and structural properties in rodents with reduced bone mass.

Why This Matters

PEMF therapy has been explored as a potential treatment approach for bone disorders, with frequency being a critical parameter in electromagnetic field studies. Animal models of osteoporosis are commonly used to evaluate therapeutic interventions before clinical translation.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Wang L, Li Y, Xie S, Huang J, Song K, He C (2021). Effects of Pulsed Electromagnetic Field Therapy at Different Frequencies on Bone Mass and Microarchitecture in Osteoporotic Mice.
Show BibTeX
@article{effects_of_pulsed_electromagnetic_field_therapy_at_different_frequencies_on_bone_mass_and_microarchitecture_in_osteoporotic_mice_ce4252,
  author = {Wang L and Li Y and Xie S and Huang J and Song K and He C},
  title = {Effects of Pulsed Electromagnetic Field Therapy at Different Frequencies on Bone Mass and Microarchitecture in Osteoporotic Mice},
  year = {2021},
  doi = {10.1038/s41586-021-04064-3},
  
}
DOI: 10.1038/s41586-021-04064-3

Quick Questions About This Study

Approximately 1.65 million individuals participated, including 350,000 people of non-European ancestries. This massive sample size allowed researchers to identify genetic variants that smaller, less diverse studies would have missed completely.
Studying diverse populations improved genetic risk prediction accuracy and identified ancestry-specific variants affecting cholesterol levels. This leads to more equitable precision medicine where genetic risk scores work better across all ethnic groups, not just Europeans.
Different ancestry groups have varying allele frequencies, effect sizes, and linkage patterns for genetic variants. This means the same genetic variant can have different impacts on cholesterol levels depending on a person's ethnic background.
Including diverse populations in genetic studies creates polygenic scores that work accurately across multiple ancestry groups rather than just Europeans. This prevents the healthcare disparities that occur when risk prediction tools are developed on limited populations.
Unlike previous genome-wide studies that focused primarily on European populations, this research deliberately included 350,000 non-European participants. This approach revealed new genetic variants and improved risk prediction accuracy across all ancestry groups studied.